Onco Therapeutics
Published 4 issues per year
ISSN Print: 2694-4642
ISSN Online: 2694-4650
Indexed in
Volume 2, 2011 Issue 2
DOI: 10.1615/ForumImmunDisTher.v2.i2
Held in Los Angeles, California, March 19−20, 2010
GUEST EDITORS:
BENJAMIN BONAVIDA, FAHD AL-MULLA, & KAM C. YEUNG
pp. v-viii
DOI: 10.1615/ForumImmunDisTher.v2.i2.10
Effects of RKIP Loss in Human and in Animal Models of Colorectal Cancer
pp. 111-118
DOI: 10.1615/ForumImmunDisTher.v2.i2.20
Induction of RKIP Expression by Anticancer Therapeutic Antibodies and Its Role in the Reversal of Chemo- and Immunoresistance
pp. 119-126
DOI: 10.1615/ForumImmunDisTher.v2.i2.30
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels
pp. 127-135
DOI: 10.1615/ForumImmunDisTher.v2.i2.40
Role of RKIP in Sensitizing Tumor Cells to Photodynamic Therapy
pp. 137-143
DOI: 10.1615/ForumImmunDisTher.v2.i2.50
Development and Application of Tissue Microarrays for Biomarker Studies
pp. 145-159
DOI: 10.1615/ForumImmunDisTher.v2.i2.60
Prognostic and Predictive Role of Raf Kinase Inhibitor Protein (RKIP) Within the RAS/ MAP Signaling Pathway in Colorectal Cancer
pp. 161-169
DOI: 10.1615/ForumImmunDisTher.v2.i2.70
Clinical Significance of RKIP and Phosphorylated RKIP Expression in Human Cancers
pp. 171-178
DOI: 10.1615/ForumImmunDisTher.v2.i2.80
Unique Pattern of Overexpression of Raf-1 Kinase Inhibitory Protein in Its Inactivated Phosphorylated Form in Human Multiple Myeloma
pp. 179-188
DOI: 10.1615/ForumImmunDisTher.v2.i2.90
Braf Mutations Are Associated With High Levels of Phosphorylated RKIP in Melanoma Cell Lines: Potential Prognostic Significance
pp. 189-194
DOI: 10.1615/ForumImmunDisTher.v2.i2.100
Role of Raf Kinase Inhibitor Protein in Hepatocellular Carcinoma
pp. 195-204
DOI: 10.1615/ForumImmunDisTher.v2.i2.110
Latest Issue
Preface: Phytochemicals for Colorectal Cancer Therapy
Novel and Latest Computational and Development of Anticancer Cancer
Isoquinoline Alkaloids: Promising Natural Compounds for Targeting Angiogenesis and Metastasis in Colon Cancer
Naringenin in the Prevention of Colon Cancer: An Updated Review
Anti-Cancer Pectins and Their Role in Colorectal Cancer Treatment
Citrus Flavones Luteolin and Apigenin Target Fundamental Mechanisms in Colon Cancer
Dietary Phytocompounds for Colon Cancer Therapy
Nano-Formulation for Curcumin and Resveratrol in Colorectal Cancer Therapy